Aster DM Healthcare’s board approved the unaudited financial results for the quarter ended September 30, 2025. In related news, Anoop Moopen resigned as Non-Executive Director effective November 6, 2025, due to business commitments. The board also approved a new registered office premises in Hyderabad and deferred a decision on the Employee Stock Option Scheme. TJ Wilson was appointed to the Nomination and Remuneration Committee.
Financial Performance Approved
The Board of Directors approved the unaudited standalone and consolidated financial results for Q2 2025. Key figures from the standalone results include:
- Revenue from operations: ₹681.81 crores
- Total income: ₹726.45 crores
- Profit before tax: ₹132.43 crores
- Profit for the period: ₹104.61 crores
The unaudited consolidated financial results show a profit for the period of ₹121.31 crores and total revenue of ₹1,197.21 crores. Deloitte Haskins & Sells issued an unmodified opinion on the financial results.
Director Resignation and Committee Changes
Anoop Moopen has resigned from his position as Non-Executive Director, effective from the close of business hours on November 6, 2025. His resignation is attributed to pre-occupations and business commitments. Consequently, he also ceases to be a member of various board committees.
TJ Wilson was appointed as a member of the Nomination and Remuneration Committee, effective November 6, 2025.
New Registered Office
The company is shifting its registered office from Karnataka to Telangana, with the new address identified in Hyderabad, pending final approval from the Regional Director. The new premises is located at: No. 7-1-450/20, Plot No. 04, Mythri Vihar, Ameerpet, Hyderabad, Telangana – 500038.
ESOP Scheme Update
The Board deferred consideration and approval of the proposed Aster DM Healthcare Limited Employee Stock Option Scheme 2025, pending further details and clarifications.
Source: BSE
